| Textiles, Apparel & Luxury Goods Industry | Consumer Discretionary Sector | Mr. Xian Zhong Li CEO | TWSE Exchange | TW0001460004 ISIN |
| TW Country | - Employees | 24 Aug 2017 Last Dividend | 29 Jul 2021 Last Split | - IPO Date |
Panion & Bf Biotech Inc. is a distinguished entity in the biotechnology pharmaceutical sector, boasting a rich history since its inception in 1976. Headquartered in Taipei, Taiwan, the company has successfully expanded its operational footprint beyond its domestic market to include significant global territories such as the United States, China, and Hong Kong. The company's robust portfolio encompasses a broad spectrum of products ranging from western medicines and cosmetics to testing reagents, food products, and chemicals. Panion & Bf Biotech Inc. prides itself on its diversified offerings, catering to various aspects of healthcare and well-being, including personal cleaning, medical aesthetics, kidney-specific therapies, pet care, and products aimed at delaying aging. Furthermore, the company is actively involved in the realms of disease treatment, prevention, and diagnosis, marking its prominence and versatility within the healthcare industry.